An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report).
Martina PanebiancoBeatrice Taurelli SalimbeniMichela RobertoMarina Chiara GarassinoPublished in: Current oncology (Toronto, Ont.) (2021)
Our case report demonstrated the relevance of DDGI in clinical practice management of a patient treated for advanced breast cancer, suggesting the role of Drug-PIN software as an easy-to-use tool to prevent adverse events during cancer treatment and to help physicians in therapeutic algorithms. However, further studies are needed to confirm these results.